Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer
Clinical trial NCT00500110 · COMPLETED
Trial details
- NCT number
- NCT00500110
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2010-02-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.